Since the advent of the insulin pump, the diabetes community has dreamed of a day when a bionic pancreas would ease the burden of diabetes. Although it has not yet become a reality, several companies and groups have started working to make this dream a reality, with as much success as Beta Bionics, which is currently developing the iLet Bionic Pancreas system. Few companies.
Excitement and anticipation about the iLet Bionic Pancreas, a pocket-sized wearable investigational medical device, grows with each new data release and with each conference passing. In a recent statement, Beta Bionics announced the appointment of Steven Russell, M.D., Ph.D., renowned in the field of diabetes and diabetes technology, as Chief Medical Officer.
Sean Saint, president and CEO of Beta Bionics, said on January 4th: in a statement“Dr. Russell is one of the foremost thought leaders in the field of diabetes technology and I have relied on him frequently over the years for his expertise and perspective. His experience with the bionic pancreas is second to none, and as we complete the regulatory review process and prepare to launch iLet in the US, there is no better person to serve as Chief Medical Officer. plug.”
An associate professor at Harvard Medical School and attending physician at Massachusetts General Hospital, Russell boasts more than 20 years of experience in managing diabetes. Principal Investigator of multiple trials involving the Bionic Pancreas, Russell was the principal investigator of more than a dozen of his studies on type 1 and type 2 diabetes.
“The bionic pancreas project has been the focus of my professional life for many years. I felt that I was able to bring in,” said Russell. “Now that the pivotal clinical trial is complete, my contribution will have the greatest impact by demonstrating medical leadership within Beta Bionics, which has received FDA clearance and is preparing to launch the iLet. We look forward to supporting diabetics and healthcare providers as all iLets move from research environments to clinical use.”
Diana Isaacs, PharmD, endocrinology clinical pharmacist, Cleveland Clinic, and Natalie Bellini, DNP, endocrinology nurse, R&B Medical Group, at the Association of Diabetes Care and Education Specialists (ADCES) 2nd Annual Diabetes Technology Conference acted as host.of The Diabetes Conversation: Technology, Therapeutics, and a Real-World Perspectivesat down with Russell to explore his role and delve into the development of the iLet Bionic Pancreas system.
all episodes of The Diabetes Conversation: Technology, Therapeutics, and a Real-World Perspective available in audio-only format at Spotify When Apple podcasts.
